The multi-cancer early detection testing market, valued at US$ 1.92 billion in 2024, is projected to grow to US$ 7.52 billion by 2033 at a CAGR of ~16.5%, driven by liquid biopsy innovations and AI. https://finance.yahoo.com/news/multi-cancer-early-detection-testing-142000104.html